|
Delayed
NYSE
16:10:00 2025-11-13 EST
|
5-day change | 1st Jan Change | ||
| 31.61 USD | -0.37% |
|
+3.30% | +6.90% |
Investment objective
Putnam BioRevolutionTM ETF Seeks long-term capital appreciation by investing mainly in common stocks of companies of any size with a focus on those that Putnam believes offer the opportunity to capitalize on a convergence of technological developments in the life sciences sector.
Off-Hours Price |
Change |
YTD change |
Weight | ||
|---|---|---|---|---|---|
 | 605.40USD | +0.40% | +4.20% | 7.08% | |
| 204.27USD | -0.47% | -10.91% | 6.67% | |
| 376.30USD | -1.00% | +23.83% | 5.42% | |
| 224.42USD | -0.58% | +20.36% | 5.2% | |
| 329.76USD | -2.54% | +5.54% | 4.97% | |
| 85.48USD | -0.49% | +27.30% | 4.32% | |
| 250.04USD | +0.50% | +9.00% | 4.16% | |
| 801.01USD | -1.15% | +3.51% | 4.05% | |
| 1,125.83USD | +0.17% | +4.82% | 3.56% | |
In partnership with
Description
| US7467298052 |
|---|
- Stock Market
- ETF
- SYNB ETF
Select your edition
All financial news and data tailored to specific country editions
